Project Grant H8E38617

Numentus Technologies Inc. received a $303,685 Project Grant award from the National Science Foundation on February 15, 2021 to develop rapid planar PCR technology for COVID-19 testing. The award was made under the NSF's Engineering program (CFDA 47.041) to support innovation and excellence in engineering research. Through this funding, Numentus will work to advance the development of planar PCR, a technology that enables highly sensitive COVID-19 detection on a single integrated testing...

This $968,765 Project Grant awarded by the National Science Foundation's (NSF) Division of Mathematical Sciences (CFDA 47.049 - Mathematical and Physical Sciences) will develop a flexible modeling framework to simulate the impact of various testing-based infection control strategies for respiratory pathogens like SARS-CoV-2. The project aims to improve our ability to control existing respiratory diseases and enhance preparedness for future pandemics. Key deliverables include: Developing a...

This $960,000 National Science Foundation project grant supports the development of a multiplexed plasmon-enhanced lateral flow assay for point-of-care detection of SARS-CoV-2 RNA and antigens. Funded under the NSF Engineering program (CFDA 47.041), the grantee, Washington University, will design, validate and build a novel diagnostic platform with sensitivity exceeding standard laboratory tests. Key deliverables include an ultrasensitive multiplexed lateral flow assay for simultaneous...

The National Science Foundation awarded a $220,000 Project Grant to the University of Connecticut under the Engineering (47.041) federal grant program. The award will fund development of a compact, field-portable biophotonics instrument for automated analysis and identification of blood cells impacted by COVID-19. The instrument aims to provide real-time sensing and diagnosis capabilities with high accuracy, specificity and sensitivity for potential early detection of COVID-19 infections. It...

The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $40.4 million cooperative agreement to Exela Pharma Sciences, LLC (Exela) to expand industrial base capabilities for COVID-19 response. With a period of performance from May 2022 through May 2034, this cooperative agreement will support Exela under the Research on Chemical and Biological Defense program (CFDA 12.360). Through this cooperative agreement, Exela will further the government's...

Federal Grant Award Summary Pace Diagnostics, Inc. received a $600,000 Project Grant from the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283), awarded on September 30, 2025, with a completion date of March 31, 2026. The grant supports the development and validation of an ultrasensitive urine tuberculosis (TB) antigen rapid detection test designed to improve the diagnosis of active tuberculosis. This initiative addresses a...

Federal Project Grant Award Summary Cubit Diagnostics, Inc. (doing business as Arete Biosciences) received a $12,704 Project Grant award dated September 30, 2025, from the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283). The project period extends through September 29, 2026. The award supports the development of an ultrasensitive, rapid, and portable nucleic acid-based test for detection of acute Hepatitis C Virus (HCV)...

Federal Project Grant Award Summary Nanohmics Inc. received a $1,047,807 project grant award dated September 30, 2025, from the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283). The award supports the development of lateral flow-electrochemiluminescent (LF-ECL) test strips and a portable reader device designed to provide ultrasensitive detection of foodborne pathogens. The project will be performed in Austin, Texas, with...

DPX Technologies LLC received a $254,536 Project Grant award from the National Science Foundation to develop high-throughput COVID-19 testing under the SBIR PHASE I program. The award, provided by NSF's Directorate for Engineering between April 1, 2021 and September 30, 2021, aims to foster innovation in engineering research and development under the Engineering (47.041) federal grant program. Specifically, DPX Technologies will leverage the funding to create products and services focused on...

Cellbae Inc. received a $174,992 Small Business Innovation Research Project Grant from the US Department of Agriculture National Institute of Food and Agriculture to develop rapid test kits for the detection of Escherichia coli O157:H7 and Salmonella enterica. The goal of the six-month project beginning July 1, 2023 is to verify the sensitivity and specificity of Cellbae's rapid test kit platform, which uses enzymatic amplification to increase detection sensitivity over conventional methods....